Maze Therapeutics (MAZE) Cash from Financing Activities (2024 - 2026)
Maze Therapeutics (MAZE) reported Cash from Financing Activities of $147.44 million for Q2 2026, compared with $612,000 a year earlier and up 248.1% from the prior quarter.
Powered by 
Analysis
Maze Therapeutics (MAZE) Cash from Financing Activities (2024 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Maze Therapeutics' Cash from Financing Activities came in at $337.14 million, up 71.9% year-over-year; for FY2025, it came in at $275.34 million, up 196.5% from FY2024.
- By year, Cash from Financing Activities came in at $92.85 million in FY2024.
- The Q2 2026 figure ranks as the highest quarterly Cash from Financing Activities in data going back to Q1 2024.
- Year over year, Cash from Financing Activities gained in two of the last four quarters, with growth averaging 138.5%.
- Per Business Quant data, the three quarters before Q2 2026 came in at $42.36 million (Q1 2026), $3.59 million (Q4 2025) and $143.76 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Maze Therapeutics | 1.51 Bn | 1.51 Bn | - | 147.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 147.44 Mn |
| Mar 31, 2026 | 42.36 Mn |
| Dec 31, 2025 | 3.59 Mn |
| Sep 30, 2025 | 143.76 Mn |
| Jun 30, 2025 | 612,000.00 |
| Mar 31, 2025 | 127.38 Mn |
| Dec 31, 2024 | 70.26 Mn |
| Sep 30, 2024 | -2.15 Mn |
| Jun 30, 2024 | 154,000.00 |
| Mar 31, 2024 | 24.58 Mn |
API Access
Maze Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=MAZE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "MAZE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=MAZE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();